Purchase Order 75N98026P00016
- Not listed
- This firm-fixed-price purchase order, valued at $24,200.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Ingenious Targeting Laboratory Inc. for the design and creation of a targeting vector. Ingenious Targeting Laboratory Inc. is a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business that provides custom gene targeting and mouse model services. The contract did not have a...
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency of the U.S. government, to Ingenious Targeting Laboratory Inc. The $9,900 purchase order contract is for the production of knockout mice from an existing embryonic stem cell line. The work supports biomedical research, which is a core part of NIDDK's mission to advance understanding and treatment of diseases like diabetes, kidney disease, and digestive...
- This firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business, to provide services related to creating conditional knockout mice. The $24,850.00 contract was awarded by the Department of Health and Human Services (HHS) and covers activities such as generating a targeting vector and embryonic stem (ES) cells, clone screening, blastocyst injection, mouse breeding, and...
- This federal contract award, with ID HHSN267200700003P, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Ingenious Targeting Laboratory Inc. (ITL), a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The $47,500.00 purchase order contract is for "CUSTOM CONDITIONAL GENE KNOCKOUT FROM ITL-REFERENCE QUW70164", which aligns with ITL's expertise in providing custom gene targeting and...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. The contract is valued at $31,245.00 and has a completion date of December 31, 2013. The contract is for the provision of ROSA26 knock-in mice, which are genetically modified mouse models used in biomedical research. The contract was set aside for small businesses, and Ingenious...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. for $25,252.00. The contract is for NICHD laboratory services, specifically sample production. No set-aside was used. Ingenious Targeting Laboratory Inc. is a minority-owned, Asian-Pacific American-owned, and self-certified small disadvantaged business that provides custom gene...
- This federal contract award, HHSN271201600200P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $114,640 firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The contract is set aside for small businesses and supports the use of mouse knockout models to determine the function of...
- The National Institute on Aging (NIA), on behalf of the National Institute on Drug Abuse (NIDA), awarded a $25,098.00 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned, small disadvantaged business, for a Custom Conditional Gpnmb cDNA cassette Knockin mouse model. The purpose is to generate a Cre-inducible Gpnmb-diphtheria toxin receptor (DTR) knock-in mouse to study the role of GPNMB+ macrophages in skeletal muscle injury response and aging. The period...
- This federal contract award, with ID HHSN276201000809P, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The $20,020 purchase order was awarded to Landy Resources, LLC, a minority-owned and self-certified small disadvantaged business, to provide transgenic mice services. The contract does not have a set-aside designation. Landy Resources, LLC also holds a $100 million indefinite...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Landy Bioresources, LLC, a minority-owned, woman-owned business. The contract is for transgenic mice services, mouse colony maintenance, genotyping, surgery, and other procedures, as requested by Jeffrey Kopp from NIDDK. The total ceiling value of the contract is $19,985.00 and the ultimate completion date is September 26, 2012. This contract...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Ingenious Targeting Laboratory Inc. for $21,889 to develop a custom conditional knockin mouse model for biomedical research purposes. The contract, which runs through February 19, 2027, represents a severable purchase order with invoicing structured across three or four payments. Ingenious Targeting Laboratory Inc., a minority-owned and self-certified small disadvantaged business located in Holbrook, New York, specializes in providing sophisticated gene targeting and mouse model services to federal research agencies. No set-aside designation was used for this award. The vendor brings substantial expertise in creating specialized research animal models for genetics and disease modeling applications. Ingenious Targeting Laboratory Inc. has an established track record with multiple federal agencies including the National Institute on Aging, National Cancer Institute, and Veterans Health Administration, delivering comparable knockin and conditional knockout mouse models through similarly structured firm fixed-price contracts. The company's prior experience includes federal grant funding from the National Institute of Allergy and Infectious Diseases focused on developing advanced humanized mouse models for COVID-19 research, demonstrating capability in cutting-edge genetic research and development relevant to the biomedical research mission of NIDDK.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 2/18/26 |